Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
9.20
+0.59 (6.85%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Oruka Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Cash & Equivalents
61.58
Short-Term Investments
314.07
Cash & Short-Term Investments
375.65
Prepaid Expenses
1.22
Total Current Assets
376.87
Property, Plant & Equipment
1.04
Long-Term Investments
18.07
Other Long-Term Assets
0.04
Total Assets
396.02
Accounts Payable
3.46
Accrued Expenses
9.37
Current Portion of Leases
0.21
Total Current Liabilities
13.04
Long-Term Leases
0.76
Total Liabilities
13.8
Common Stock
0.04
Additional Paid-In Capital
463.02
Retained Earnings
-83.72
Comprehensive Income & Other
-0.04
Total Common Equity
379.29
Shareholders' Equity
382.22
Total Liabilities & Equity
396.02
Total Debt
0.97
Net Cash (Debt)
392.75
Net Cash Per Share
23.39
Filing Date Shares Outstanding
37.44
Total Common Shares Outstanding
37.44
Working Capital
363.83
Book Value Per Share
10.13
Tangible Book Value
379.29
Tangible Book Value Per Share
10.13
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q